Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 26 member 11 (SLC26A11) is a sodium-independent, DIDS-sensitive anion transporter, primarily mediating the movement of sulfate, bicarbonate, chloride, and oxalate ions across cellular membranes. It is a member of the SLC26 family of anion exchangers that play essential roles in maintaining intracellular electrolyte balance and homeostasis. SLC26A11 is highly expressed in placenta, kidney, and brain, and is thought to facilitate specialized sulfate transport into high endothelial venule endothelial cells, potentially cooperating with SLC26A2. Beyond surface ion exchange, SLC26A11 has emerging importance in lysosomal function and regulation of degradative pathways, suggesting roles in autophagy and cellular clearance as part of the CLEAR network regulated by TFEB. Diseases associated with dysfunction of SLC26A11 include mucopolysaccharidosis IIIA and possibly other lysosomal storage diseases.
Inhibition of sulfate transport by anion exchanger inhibitors (e.g., DIDS); transport of sulfate, chloride, bicarbonate, oxalate across the membrane
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 26 member 11 (SLC26A11).